Lipella Pharmaceuticals Highlighted Clinical Data On LP-20, A Novel MRI Contrast Agent Designed For Diagnosing Interstitial Cystitis And Detecting Bladder Cancer At The 5th International Consultation On Interstitial Cystitis Japan In Kyoto, Japan
Lipella Pharmaceuticals Highlighted Clinical Data On LP-20, A Novel MRI Contrast Agent Designed For Diagnosing Interstitial Cystitis And Detecting Bladder Cancer At The 5th International Consultation On Interstitial Cystitis Japan In Kyoto, Japan
Lipella Pharmaceuticals在日本京都舉行的第5屆國際陰道炎諮詢會上，重點介紹了LP-20，一種新型MRI造影劑，用於診斷間質性膀胱炎和檢測膀胱癌。
Lipella Pharmaceuticals Highlighted Clinical Data On LP-20, A Novel MRI Contrast Agent Designed For Diagnosing Interstitial Cystitis And Detecting Bladder Cancer At The 5th International Consultation On Interstitial Cystitis Japan In Kyoto, Japan
Lipella Pharmaceuticals在日本京都舉行的第5屆國際陰道炎諮詢會上，重點介紹了LP-20，一種新型MRI造影劑，用於診斷間質性膀胱炎和檢測膀胱癌。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。